Healthcare professionals should assess retinopathy status before initiating GLP-1 receptor agonists and consider ophthalmology referral for patients with moderate to severe non-proliferative or proliferative diabetic retinopathy, particularly if rapid glucose improvements are anticipated
Public health measures and continued clinical innovations are needed to ensure an acceptable risk-benefit profile
Together, our studies demonstrate that GLP-1(2836) protects the heart from IRI by activating sAC through an oxygen-sparing substrate shift mediated by MTP, with reductions in metabolic oxidative stress
Treatment with tirzepatide was associated with clinically relevant reductions in biomarkers of fibrosis and hepatic inflammation [5]
Operators across the US are rolling out lighter menus, protein-forward meals and smaller portions designed around fullness rather than excess
Similarly, several case reports describe the improvement and near resolution of psoriasis following weight loss achieved through intestinal bypass surgery [15]